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Pharmaceuticals can enter the soil environment when animal slurries and sewage sludge are applied to
land as a fertiliser or during irrigation with contaminated water. These pharmaceuticals may then be
taken up by soil organisms possibly resulting in toxic effects and/or exposure of organisms higher up the
food chain. This study investigated the inﬂuence of soil properties on the uptake and depuration of
pharmaceuticals (carbamazepine, diclofenac, ﬂuoxetine and orlistat) in the earthworm Eisenia fetida. The
uptake and accumulation of pharmaceuticals into E. fetida changed depending on soil type. Orlistat
exhibited the highest pore water based bioconcentration factors (BCFs) and displayed the largest dif-
ferences between soil types with BCFs ranging between 30.5 and 115.9. For carbamazepine, diclofenac
and ﬂuoxetine BCFs ranged between 1.1 and 1.6, 7.0 and 69.6 and 14.1 and 20.4 respectively. Additional
analysis demonstrated that in certain treatments the presence of these chemicals in the soil matrices
changed the soil pH over time, with a statistically signiﬁcant pH difference to control samples. The in-
ternal pH of E. fetida also changed as a result of incubation in pharmaceutically spiked soil, in comparison
to the control earthworms. These results demonstrate that a combination of soil properties and phar-
maceutical physico-chemical properties are important in terms of predicting pharmaceutical uptake in
terrestrial systems and that pharmaceuticals can modify soil and internal earthworm chemistry which
may hold wider implications for risk assessment.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Following use, pharmaceuticals are typically excreted to the
sewage system and are then transported to wastewater treatment
plants. As many pharmaceuticals are resistant to degradation in
wastewater treatment processes they will be present in the
wastewater treatment efﬂuents and in the sludge by-products (Jelic
et al., 2011). The land application of sewage sludge (biosolids) as a
fertiliser and use of reclaimed waste water for irrigation purposes
therefore provides a route of entry for pharmaceuticals into the
terrestrial environment (Dalkmann et al., 2012; Duran-Alvarez
et al., 2009; Kinney et al., 2006a, 2006b; Siemens et al., 2008).
Concerns have therefore been raised over the potential uptake of
pharmaceuticals into terrestrial organisms and the potential effects
on soil-dwelling organisms and organisms that feed on thesee by Klaus Kummerer.
).
r Ltd. This is an open access article(Arnold et al., 2014). A handful of studies have recently demon-
strated that pharmaceuticals can be taken up from soils and accu-
mulate in invertebrates such as earthworms (Berge and Vulliet,
2015; Carter et al., 2014b; Kinney et al., 2008).
Earthworms are key terrestrial invertebrates with respect to the
role they have in maintaining a fertile soil environment (Edwards,
2004). Earthworms are also a key food source for many predator
species such as birds. Understanding the uptake of chemicals into
earthworms is therefore not only a prerequisite to understanding
the risks chemicals pose to earthworm populations, but also the
potential effects of secondary poisoning on predators. Earthworms
are at the base of many food chains and thus if chemicals are taken
up into the earthworms they can facilitate the movement of
chemicals into the food web via bioaccumulation and bio-
magniﬁcation processes (Shore et al., 2014).
We have previously investigated the uptake and depuration
kinetics of four pharmaceuticals in the earthworm, Eisenia fetida
(Carter et al., 2014b). Pore-water based bioconcentration factors
(BCFs) increased in the order of
carbamazepine < diclofenac < ﬂuoxetine < orlistat and rangedunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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organic compounds, uptake of ionisable pharmaceuticals was not
driven by the hydrophobicity (log Kow) of the chemical alone. Our
previous study exposed the earthworms to pharmaceutical resi-
dues in one soil type only. It is well known that pharmaceuticals
can behave very differently in different soil types (Drillia et al.,
2005; Monteiro and Boxall, 2009). For example, distribution co-
efﬁcients (Kd) between soil particles and soil pore waters are
known to vary by several orders of magnitude for a range of
pharmaceuticals in soils with varying properties (Kodesova et al.,
2015; ter Laak et al., 2006). As the distribution of pharmaceuticals
between the soil and porewater inﬂuences the bioavailable fraction
of these chemicals and thus uptake by earthworms, it is therefore
likely that uptake of pharmaceuticals could also vary signiﬁcantly
across soils.
However, knowledge of the relationships between soil proper-
ties and pharmaceutical uptake in terrestrial species is very limited.
There is therefore a real need to generate data on the uptake of
pharmaceuticals into terrestrial invertebrates from soils with
different characteristics in order to identify key drivers affecting
uptake. This will help to develop uptake modelling approaches for
use in environmental risk assessment. Therefore, in this study we
build upon our previously published results demonstrating phar-
maceutical uptake by the earthworm Eisenia fetida in a single soil
type (Carter et al., 2014b) and explore the effects of soil properties
on the uptake and depuration of pharmaceuticals in order to help
elucidate the relationships between soil properties and uptake. The
study focused on one acidic (diclofenac), one basic (ﬂuoxetine) and
two neutral (carbamazepine and orlistat) pharmaceuticals, from a
variety of therapeutic uses and covering a range of physico-
chemical properties (e.g. log Kow 2.25e8.19) (Table 1). With the
exception of orlistat, these pharmaceuticals have been previously
detected in wastewater irrigated soils in concentrations <7 mg/kg
and therefore it is important to understand the potential uptake of
these chemicals by soil dwelling organisms. To help explain any
potential differences in uptake and depuration, parallel studies
were performed to assess the fate and distribution of the study
pharmaceuticals in test soils.2. Materials and methods
2.1. Pharmaceuticals and reagents
All studies were performed using 14C labelled compounds.
Radiolabeled ﬂuoxetine [methyl-14C] and carbamazepine [carbon-
yl-14C] were obtained from American Radiolabeled Chemicals (St.
Louis, MO, USA), diclofenac [U e 14C] was obtained from Perkin
Elmer (Boston, MA, USA) and orlistat [tridecanyl-2-14C] was pro-
vided by GlaxoSmithKline (GSK) (Middlesex, UK). Physico-chemical
properties and speciﬁc activities for the pharmaceuticals can be
found in Table 1. Acetonitrile (99.9%), methanol (99.9%) and ethyl
acetate (99.9%) were obtained from Fisher Scientiﬁc (Lough-
borough, UK).Table 1
Test pharmaceutical physico-chemical properties.
Pharmaceutical Class CASa Molecular weight (g m
Carbamazepine Anti-epileptic 298-46-4 236.30
Diclofenac Anti-inﬂammatory 15307-79-6 318.13
Fluoxetine Anti-depressant 54910-89-3 345.80
Orlistat Weight loss aid 96829-58-2 497.74
a CAS obtained from the Chemical Abstracts Service.
b Log Kow values obtained from KOWWIN v. 1.68 database, USEPA EPI suite 4.1 progr
c pKa values were predicted using the University of Georgia SPARC database v. 4.2 (ht2.2. Test soils
Five standard test soils were obtained from LUFA Speyer (Speyer,
Germany). The soils, 2.1, 2.3, 2.4, 5M and 6S, included clay loam,
silty sand and loamy sand varieties and were chosen to provide a
range of soil characteristics including varying soil pH, organic car-
bon content, cation exchange capacity and particle size distribu-
tions (Table 2). Soils were air dried and sieved to 2 mm prior to
testing to ensure homogeneity.
2.3. Test organism
E. fetidawere obtained fromBlades Biological Ltd. (Kent, UK) and
cultured in a medium of peat and cow manure (50:50) (Dean's
Garden Centre, York, UK), kept moist with deionised water at room
temperature (20 ± 3 C). The earthworms were fed twice weekly
with homogenised mashed potato powder. E. fetida were obtained
from a single species culture and cultures were maintained for at
least four generations prior to use in the uptake studies. The lipid
content of E. fetida, determined using the method of Folch et al.,
(Folch et al., 1957), was 5.11 ± 0.29% (wet weight) (Carter et al.,
2014b).
2.4. Fate studies
For each pharmaceutical, triplicate beakers of each soil (2.1, 2.3,
2.4, 5M and 6S) (35 ± 1 g) were prepared to sample at eight time
points (0 and 6 h, 1, 3, 7, 10, 14 and 21 d) where pore water and soil
samples would be analysed for radioactivity and pH. Detailed
sample preparation and analysis techniques can be found in Carter
et al. (2014b). Brieﬂy, labelled pharmaceuticals were added, indi-
vidually, to each of the ﬁve soils using 125e165 ml of a carrier sol-
vent to create nominal concentrations of 26, 25, 28 and 44 mg/kg of
carbamazepine, diclofenac, ﬂuoxetine and orlistat respectively. For
carbamazepine and ﬂuoxetine, ethanol was used as the carrier
solvent; for diclofenac, methanol was used and orlistat was applied
in acetonitrile. After spiking, each test beaker was left for 2 h and
then mixed by hand to create an even distribution of the phar-
maceutical within the sample. Following spiking and mixing, the
carrier solvents were allowed to evaporate from the test beakers for
48 h. Blank and solvent controls were also prepared. The moisture
content of all soils was adjusted, and maintained at 40e60% of the
maximum water holding capacity (MWHC) by addition of deion-
ised water on a daily basis. All experiments were undertaken at
20 ± 2

C, using a 16:8 light/dark cycle [600 lx] and 60% humidity.
2.5. Uptake and depuration studies
The uptake and depuration studies followed the ‘minimised’
approach described in Carter et al. (2014a). The experiments con-
sisted of exposing a single earthworm to each pharmaceutical in
each of the ﬁve soil types. There were six replicates per treatment.
Soils were prepared in glass jars (50 ± 1 g) and spiked with the fourol1) Log Kowb Acid/Base pKac Speciﬁc activity (GBq mmol1)
2.25 Neutral N/A 0.74
4.02 Acid 4.12 2.29
4.65 Base 9.53 2.04
8.19 Neutral N/A 2.05
amme.
tp://ibmlc2.chem.uga.edu/sparc) Accessed: 25/05/2012.
Table 2
Soil properties for the standard test LUFA Speyer soils. Mean values of different batch analyses are provided ± standard deviation (SD).
Standard soil type 2.1 2.3 2.4 5M 6S
Organic carbon in % C 0.7 ± 0.1 0.9 ± 0.1 2.3 ± 0.3 1.0 ± 0.2 1.6 ± 0.1
Nitrogen in % N 0.05 ± 0.01 0.08 ± 0.02 0.2 ± 0.04 0.1 ± 0.02 0.2 ± 0.02
pH value (0.01 M CaCl2) 5.1 ± 0.3 6.8 ± 0.2 7.2 ± 0.2 7.3 ± 0.1 7.1 ± 0.1
Cation exchange capacity (meq/100 g) 4.3 ± 0.5 10.9 ± 1.1 31.4 ± 4.6 16.6 ± 2.8 27.2 ± 1.4
Soil type Silty sand Silty sand Clayey loam Loamy sand Clayey loam
Water holding capacity (g/100 g) 31.1 ± 2.1 37.3 ± 1.8 44.1 ± 1.2 39.5 ± 2.9 40.5 ± 2.1
Particle size (mm) distribution according to USDA (%)
<0.002 2.8 ± 1.1 8.5 ± 1.7 25.9 ± 2.1 11.1 ± 1.2 40.5 ± 2.1
0.002e0.05 10.2 ± 1.8 28.4 ± 4.5 40.5 ± 1.0 29.7 ± 2.8 35.0 ± 2.9
0.05e2.0 87.0 ± 1.5 63.1 ± 5.0 33.6 ± 1.8 59.2 ± 3.2 24.5 ± 3.5
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methods to those in the fate studies. In total there were 60 spiked
soils per pharmaceutical compound (12 spiked soils  5 soil types).
For each soil type, blank (earthworm exposed in uncontaminated
soil; n ¼ 6) and solvent controls (earthworm exposed in soil spiked
with solvent only; n ¼ 6) were prepared. Adult E. fetida (ranging in
mass from 220 to 450 mg wet weight, and with average mass
299 mg (standard deviation 54 mg)) (Supplementary Table 1) were
then added to each test beaker after having been acclimatised
under experimental conditions for 48 h in non-treated test soil.
After addition to the soil surface, the time it took for each earth-
worm to completely burrow into the soil was also noted. Earth-
worm beakers were incubated under controlled conditions and
moisture adjustments were performed as reported in the fate
study. For each pharmaceutical treatment in each soil type, six
replicates were sampled at the end of the uptake period (21 d) and
six at the end of the depuration phase (42 d). E. fetida were then
removed from the vessels, and transferred to moist ﬁlter paper for
24 h to allow them to purge their guts. The earthworms were then
frozen at 20 C until analysis.
2.6. Preparation of samples for analysis
Pore-water was extracted from the soils using a centrifugation
method and soil and earthworms were extracted using liquid
extraction methods similar to those outlined in Carter et al. (2014b)
and are provided in the Supplementary materials together with the
extraction recoveries (Supplementary Table 2). Before E. fetida
extraction, the internal pH of each worm was measured using an
Orion™ pHmicroelectrode (Thermo Scientiﬁc, UK). Eachwormwas
dissected across the segments from the anterior to the posterior.
The pH probe was then placed into the earthworm tissue avoiding
internal organs, to determine internal tissue pH. Soil pH measure-
ments were also obtained by preparing a soil solution from each
test vessel. Methanol, ethyl acetate, acetonitrile:water (70:30 v/v)
and acetonitrile were then used as solvents in the E. fetida and soil
extractions for carbamazepine, diclofenac, ﬂuoxetine and orlistat
respectively. Average recoveries ranged from 72.4 to 94.7% for the
pharmaceuticals in the ﬁve different soil types (detailed recovery
information provided in the Supporting Information). Recoveries
ranged from 86.3 (ﬂuoxetine) to 100.9% (carbamazepine and
diclofenac) for the earthworm extraction methods. As previous
work has demonstrated that orlistat and diclofenac form irrevers-
ibly bound residues with soil (Carter et al., 2014b); combustion
analysis of these samples was also performed using a Perkin Elmer
307 Sample Oxidiser (see the Supporting Information for a
description of the soil combustion procedure).
2.6.1. Liquid scintillation counting
Radioactivity in soil porewater, soil and earthworm extracts wasdetermined using Liquid Scintillation Counting (LSC) using a
Beckman LS 6500 LSC counter (Beckman Coulter Inc., Fullerton, CA,
USA). Samples were counted three times for 5 min. Counts were
corrected for background activity by using blank controls. Counting
efﬁciency and colour quenching were corrected for using the
external standard ratio method.
2.7. Calculating BCFekinetic modelling
Previous work was able to elucidate that approximately 23% of
the soil gut contents remained in the E. fetida gut after 24 h of
purging. In the present study, after measuring the amount of gut
contents eliminated during the 24 h period, the amount of soil
remaining in the gut was calculated and then a correction factor
was applied to the measured radioactivity in the earthworm ex-
tracts to account for soil-associated pharmaceuticals present in the
gut and ensure that the analysis focussed on the tissue concen-
trations only (see Carter et al. (2014b) for more detail). Measured
radioactivity in the E. fetida extracts were then used to calculate
uptake and depuration rates for each study compound in each soil
type using Equation (1) and Equation (2). For a full explanation of
BCF calculations see Carter et al. (2014a).
k2 ¼ ðln Ct1  ln Ct2Þ=td (1)
k1 ¼ k2*Ct1

Cpw 1 ek2tu
 
(2)
Where k2 is the depuration rate constant, k1 is the uptake rate
constant, Cpw is average pore water concentration during exposure
phase (n ¼ 3), Ct1 and Ct2 are the average E. fetida concentrations
after the uptake and depuration phases respectively (n ¼ 6) and tu,
td are the length of uptake and depuration period respectively. The
uptake and depuration rates were then used to estimate pore water
based kinetic bioconcentration factors (Equation (3)).
BCFminimised ¼ k1=k2 (3)
Soil based bioaccumulation factors (BSAF) were estimated from
the pore water based BCFs for all pharmaceuticals using soil water
partition coefﬁcients (Kd) calculated from fate studies (Equation
(4)). A soil water partition coefﬁcient, deﬁned as a ratio of the
concentration of each pharmaceutical in the soil and pore water
during the 21 d fate study, was determined for each replicate, at
each sampling point for all soils. An average Kd across all replicates
and sampling points was then calculated for each pharmaceutical
in each soil type (Table 2).
BSAFsoil ¼ BCFminimised=Kd (4)
Regression analysis was then performed to compare BSAF values
and soil properties and BCF values to pore water properties.
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Statistical analysis was performed using SigmaPlot (v.12) with a
signiﬁcance level of 0.05. Prior to all tests, the data were tested for
normality and equal variance using a ShapiroeWilk and Leve-
neeMediane test; respectively to ensure the ANOVA conditions
were satisﬁed. If the normality test failed then the one-way
ANOVA was instead performed on ranks. Firstly, data on burrow-
ing times were tested against the control treatment using a one-
way ANOVA, to assess any pharmaceutical effects on earthworm
behaviour. A two-way analysis of variance (ANOVA) was per-
formed, keeping study type (blank or treatment) as repeated and
time as a variable factor. Endpoints tested included the differences
in soil pH across time and in comparison to control samples,
additional pair-wise comparisons of the data were performed ac-
cording to the Holm-Sidak method. Further two-way ANOVAs
were performed to check differences in internal E. fetida pH
exposed in the same soil but under different pharmaceutical
treatments (including controls) at both the end of the uptake and
depuration phases.
3. Results
3.1. Pharmaceutical fate in soils
Measurements of extractable radioactivity in the soil and pore
water changed over time and these changes appear to be depen-
dent on pharmaceutical compound and in a number of cases, on
soil type (Fig. 1). It is important to note that as the fate experiments
were performed without earthworms, their presence might have
affected the fate differently. Nevertheless the results can
contribute to our understanding on the behaviour of pharmaceu-
ticals in the soil and pore water over time and provide a likely
indication as what the earthworms would be exposed to. In most
soil types, measured radioactivity in soil tended to decrease after
1d. Carbamazepine was fairly persistent in all soil types whilst
initial results showed rapid dissipation of diclofenac and orlistat
from the test beakers. However, combustion analysis conﬁrmed
the formation of non-extractable (bound) residues (NER's) in both
the diclofenac and orlistat studies. NER fractions increased over
time reaching a maximum 49.9% of the total radioactivity in soil
2.4 and 97.4% in soil 2.3 of for the orlistat and diclofenac exposures
respectively (see Supplementary Figure 1 and 2 for additional in-
formation on the mass balance). Changes in soil pH over time, and
in comparison to the controls were noted over 21 d as a result of
the presence of pharmaceuticals in the soil (diclofenac, ﬂuoxetine
and orlistat) in the soil matrix (p < 0.05) (Fig. 2). In comparison to
the control soils, soil pH was overall signiﬁcantly different in all
soil ﬁve types for the ﬂuoxetine and orlistat exposures and in the
diclofenac treatment with the exception of soil 2.3 (silty sand)
(p < 0.05). Whilst these changes appear to be inﬂuenced by soil
type it is important to note that changes in soil pH were not
consistent over time.
Concentrations of the pharmaceuticals in the pore-water
differed to a greater extent, depending on soil type, in compari-
son to the soil concentrations (Fig. 1). Soil 2.1 (silty sand) generally
had the highest pore water concentrations for all pharmaceuticals
while the clayey loam soil (soil 2.4) generally had the lowest con-
centrations. From 10 d onwards, pore-water concentrations tended
to decrease in all soil types especially for diclofenac, ﬂuoxetine and
orlistat. This was most evident in the silty sand soil (soil 2.1) for all
pharmaceuticals.
The soilewater distribution (Kd) for the individual pharma-
ceuticals varied across soil types with Kd values for carbamaze-
pine ranging from 1.34 to 4.45 L/kg, diclofenac ranging from 5.63to 18.37 L/kg, ﬂuoxetine ranging from 55.48 to 71.44 L/kg and
orlistat ranging from 28.99 to 110.01 L/kg (Table 3). Over the
initial 10 d of the uptake phase, orlistat became less strongly
bound to the soil as the amount recovered in the solvent
extraction increased whilst the combustion analysis concentra-
tions decreased.
3.2. Earthworm uptake
Overall mortality during the experiment was less than 4%
across all exposure scenarios and whilst the mean earthworm
mass did increase over the course of the experiment this was less
than 20%. No signiﬁcant difference in the burrowing times be-
tween treatments and controls was noted for any of the soil types
(p > 0.05), and therefore based on these ﬁndings effects of toxicity
on uptake can likely be excluded. All four study compounds were
found to be taken up from all soil types into E. fetida (Table 3).
Based on previous research using E. fetida, the uptake measured in
the carbamazepine and ﬂuoxetine studies is likely to be that of the
parent compound (Carter et al., 2014b). The radioactivity
measured in the diclofenac study is however more likely to be a
transformation product as the parent compound was unable to be
detected in E. fetida samples exposed to unlabelled diclofenac
(Carter et al., 2014b). The transformation of pharmaceuticals can
however be inﬂuenced by environmental factors, such as pH and
temperature (Fatta-Kassinos et al., 2011). Therefore, it is important
to note that in this study earthworm exposure in different soil
types may have resulted in variable chemical metabolism in the
soil or E. fetida. The ﬂuoxetine treatment had the greatest uptake
rate (k1) in all soils (0.96e2.35 mL/g d1), whilst the carbamaze-
pine treatment had the fastest depuration rate (k2) in all ﬁve soils
(0.16e0.24 d1) (Table 3). This is comparable to previous work
with E. fetida in a single soil type (Carter et al., 2014b). Highest
pore water-based BCFs were observed for orlistat (<115.88) and
the smallest BCFs were seen for carbamazepine. BCFs of the in-
dividual compounds were found to differ across soil types, with
greatest variability observed for diclofenac (7.02e69.57) and orli-
stat (30.50e115.88), whereas smaller variability of the BCFs was
noted for ﬂuoxetine (14.09e20.42) and carbamazepine (1.05e1.61)
(Table 3).
BSAFs were generally low (<2), especially for carbamazepine
and ﬂuoxetine. Similarly to the pore-water based BCFs, the diclo-
fenac exposure resulted in the largest range of BSAFs, up to 12.36
in the loamy sand soil (soil 5M). There was a signiﬁcant difference
in internal E. fetida pH after exposure to pharmaceuticals in
comparison to control earthworms (p < 0.05). However, this was
not true for all soil types as there was no signiﬁcant interaction
between treatment or time with internal earthworm pH exposed
in soil 6S (clayey loam) (Fig. 3). Fluoxetine appears to have the
strongest inﬂuence on internal earthworm pH as this exposure
resulted in signiﬁcant differences to the control for all soils, with
the exception of the clayey loam soil (soil 6S) (p < 0.05). Signiﬁ-
cant differences were also observed between measurements made
in earthworms sampled at the end of the uptake and depuration
phase respectively (Fig. 3). For the ﬂuoxetine exposure, trans-
ferring the earthworms to clean soil appears to reduce the internal
pH (p < 0.001) whereas for the remaining treatments earthworm
pH increased in those earthworms sampled at the end of the
depuration phase (p < 0.05). Interestingly, not only does the in-
ternal pH change between different soil types it was also signiﬁ-
cantly different between different pharmaceutical treatments in a
single soil type at the end of the uptake phase (except soil 5M
(loamy sand) and 6S (clayey loam)) (p < 0.05) and the end of the
depuration phase (except soil 2.1 (silty sand) and 6S (clayey loam))
(p < 0.05) (Fig. 3).
Fig. 1. Dissipation of radioactivity measured in carbamazepine, diclofenac, ﬂuoxetine and orlistat studies in soil and pore water throughout 21 day in ﬁve different soil types 2.1
(dash and dotted); 2.3 (grey); 2.4 (black); 5M (dotted) and 6S (dash). Average C(t)/C(0) ratio provided with ±standard deviation, where C(t) is concentration at time of sampling
throughout the fate study and C(0) is concentration at 0 d.
L.J. Carter et al. / Environmental Pollution 213 (2016) 922e931926
Fig. 2. Changes in soil pH over time for different soil types under diclofenac, ﬂuoxetine and orlistat exposure. Average measurements provided (n ¼ 3) together with standard
deviation. Results which are signiﬁcantly different to the control measurement are denoted by a ﬁlled diamond and results not signiﬁcantly different to the control are an indicated
by an open diamond (p < 0.05).
L.J. Carter et al. / Environmental Pollution 213 (2016) 922e931 9274. Discussion
4.1. Pharmaceutical fate in soils
In agreement with previous research, carbamazepine was found
to be persistent in all soil types (Monteiro and Boxall, 2009;
Williams et al., 2006). Conversely a decline in radioactivity was
measured in the diclofenac study, possible reasons for this include
volatilisation and/or mineralisation (Fig. 1, Supplementary
Figure 1). The Kd values fell within the ranges found in previous
research for carbamazepine (0.49e37 L/kg (Drillia et al., 2005)) and
diclofenac (1.21e17.72 L/kg, (Xu et al., 2009)) however for ﬂuoxe-
tine values were lower than previously reported (992e2546 L/kg,
(Kwon and Armbrust, 2008)). Other than research primarily on
veterinary antibiotics (Heise et al., 2006; Schmidt et al., 2008) this is
some of the ﬁrst published work to demonstrate that human
pharmaceuticals can form irreversibly bound residues with soil and
the degree of NER can be inﬂuenced by soil type (Supplementary
Figure 1 and 2). Previous work has shown that non extractable
pesticide residues remain available for uptake by earthworms(Gevao et al., 2001) and thus may be contributing to the uptake
observed in this study.
The test soils selected for this study included soils with similar
classiﬁcations, for example soil 2.1 and 2.3 are both ‘silty sand’ and
soil 2.4 and 6S are both ‘clayey loam’. However, the behaviour of the
pharmaceuticals in soils within the same class was quite different.
For the chemicals that were unionised in the test system, carba-
mazepine and orlistat, porewater concentrations were greater in
the silty sand soil that had the lowest organic content (soil 2.3 < soil
2.1). This would suggest hydrophobic interactions with the organic
matter are driving the sorption process and thus the bioavailable
fraction in the pore water. For the cationic pharmaceutical, ﬂuox-
etine, where it has been suggested that sorption to soil is regulated
by the cation exchange sites present on the clay minerals and
organic matter (Droge and Goss, 2013), higher pore water con-
centrations were measured in soils with lower CEC within the same
soil type (soil 2.3< soil 2.1 and soil 6S< soil 2.4). This would suggest
that the fate of pharmaceuticals in soils is due to a combination of
soil and pharmaceutical properties.
To the best of our knowledge, this is some of the ﬁrst research to
Table 3
Results from minimised design experiments in ﬁve soil types showing average measured concentrations in E. fetida (n ¼ 6) at the end of 21 d uptake phase (Ct1) and 21 d
depuration phase (Ct2) and average concentration (n¼ 3) of pharmaceutical in the pore water during the uptake phase (Cpw) (±standard deviation). Calculated uptake (k1) and
depuration rates (k2) are presented along with pore water based BCF values derived using the minimised design approach. Soil/water adsorption coefﬁcients (Kd) are also
provided with soil BSAF estimates based on Kd values.
Soil type Ct1 Bq/g (internal) Ct2 Bq/g (internal) Cpw (Bq/mL) k2 (dep.
Rate) (d1)
k1 (uptake
rate) (mL/
g d1)
Pore water BCF Soil Kd (average 21 d) Soil BSAF
Carbamazepine
2.1
76.13 ± 13.33
1.49 ± 0.68
59.78 ± 14.61
0.187 0.24
1.30
1.34 0.97
2.3
27.94 ± 6.11
0.17 ± 0.03
18.37 ± 3.57
0.243 0.37
1.53
3.87 0.40
2.4
25.79 ± 2.94
0.28 ± 0.74
16.24 ± 2.27
0.215 0.35
1.61
4.45 0.36
5M
34.49 ± 3.09
0.52 ± 0.52
33.37 ± 5.58
0.200 0.21
1.05
2.20 0.48
6S
35.10 ± 4.82
1.22 ± 0.36
23.35 ± 6.03
0.160 0.25
1.56
3.44 0.45
Diclofenac
2.1
413.80 ± 166.08
233.65 ± 141.58
33.28 ± 13.72
0.027 0.77
28.56
6.88 4.15
2.3
34.12 ± 13.76
31.67 ± 12.88
31.50 ± 11.67
0.004 0.05
15.04
7.25 2.07
2.4
31.61 ± 9.61
26.64 ± 8.74
10.85 ± 1.92
0.008 0.15
18.53
18.37 1.01
5M
34.59 ± 3.52
34.14 ± 11.51
38.20 ± 14.80
0.001 0.04
69.57
5.63 12.36
6S
67.99 ± 11.95
42.29 ± 22.54
25.64 ± 9.93
0.023 0.16
7.02
6.37 1.10
Fluoxetine
2.1
61.94 ± 8.65
5.52 ± 0.96
3.33 ± 0.58
0.115 2.35
20.42
55.48 0.37
2.3
45.27 ± 5.81
7.82 ± 2.36
2.77 ± 0.42
0.084 1.65
19.74
64.85 0.32
2.4
22.46 ± 3.55
5.41 ± 1.78
2.10 ± 0.29
0.068 0.96
14.09
71.44 0.20
5M
34.70 ± 6.66
10.09 ± 3.69
2.55 ± 0.29
0.059 1.13
19.18
64.06 0.30
6S
28.91 ± 12.23
2.97 ± 0.81
1.91 ± 0.61
0.108 1.83
16.89
58.17 0.29
Orlistat
2.1
116.83 ± 19.03
57.15 ± 6.97
7.50 ± 3.22
0.034 1.04
30.50
28.99 1.05
2.3
56.91 ± 8.12
47.04 ± 9.52
2.83 ± 1.45
0.009 1.05
115.88
75.10 1.54
2.4
35.43 ± 6.14
26.03 ± 5.86
1.78 ± 0.78
0.015 1.10
74.95
110.01 0.75
5M
56.88 ± 15.30
26.61 ± 13.73
2.60 ± 1.58
0.036 1.49
41.13
84.59 0.49
6S
37.93 ± 7.12
32.68 ± 14.15
3.98 ± 1.37
0.007 0.49
68.86
51.30 1.34
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ceuticals to the soil matrices. Both pharmaceutical physico-
chemical properties and soil type appear to inﬂuence the degree
of pH change, as changes in comparison to the controls and over
timewere not consistent across all treatment combinations (Fig. 2).
Further analysis should explore this with a wider range of chem-
icals and soil types. The environment comprises of a wide range of
ionisable chemicals and different soil types and these initial results
may have considerable impact on environmental modelling sce-
narios, which currently do not account for changes in pH. Changes
in soil pH may have signiﬁcant effects on the fate of chemicals in
the terrestrial environment by affecting processes such as sorption,
leaching and degradation and should be considered in a modelling
framework (Franco et al., 2009).
4.2. Relationships between soil and pore water properties with
earthworm uptake
Regression analysis between various soil properties and BSAFvalues failed to highlight key factors which may be responsible for
pharmaceutical uptake into earthworms. Previously clay and
organic matter content have been shown to inﬂuence bioavail-
ability of organic pollutants in soils (Chung and Alexander, 1998;
Weber and Weed, 1968; White et al., 1997). Speciﬁcally, research
has shown greater uptake into earthworms of the neutral organic
compound phenanthrene in soils with higher clay content (White
et al., 1997) however this was not observed with soil BSAF values
calculated in this study.
This study used soils with an environmentally realistic pH range
(6.6e8.2). Therefore, this may account for the lack of clear effect of
soil pH on the uptake of pharmaceuticals into earthworms as the
pH rangewas fairly small. Where notable differences in BSAFs were
observed in the diclofenac study (Table 3), diclofenac was always
extensively ionised (>99% Supplementary Table 3) and no rela-
tionship between BSAF and soil pH was found. Additional studies
could explore pharmaceutical exposure in soils with a wider pH
range as research has shown E. fetida can survive in soils as low as
pH 4.3 (Sims and Gerard, 1999) which may elucidate relationships
Fig. 3. Average measured internal pH in E. fetida in different soil types at the end of the uptake (grey) and depuration (white) phase after exposure to carbamazepine, diclofenac
ﬂuoxetine and orlistat (n ¼ 6, ±standard deviation). Measurements which are signiﬁcantly different to the control are denoted by an ‘a’ and where there is a statistically signiﬁcant
difference between internal pH in uptake phase and depuration phase these are denoted by a ‘b’ (p < 0.05).
L.J. Carter et al. / Environmental Pollution 213 (2016) 922e931 929between pharmaceutical accumulation and pH effects such as those
demonstrated in the aquatic environment (Nakamura et al., 2008).
As clear relationships between soil properties and earthworm
BSAFs were unable to be found, it would suggest earthworm uptake
is a complex interaction of a variety of factors and processes and
does not exclusively rely on a single soil parameter. In addition,
previous research has shown the ingestion of soil particles plays a
very minor role in the accumulation of chemicals (log Kow < 6) in
earthworms (Jager et al., 2003; Vijver et al., 2003). Instead, for a
large proportion of chemicals, uptake via diffusion across the
earthworm skin dominates. Therefore, understanding how pore
water properties relate to earthworm uptake and BCFs may be a
more appropriate approach to evaluate differences in pharmaceu-
tical accumulation between soil types. Highest internal concen-
trations were observed in exposures which had the highest pore
water concentration of the respective pharmaceutical and therefore
would suggest the bioavailability of chemicals in pore water is a
limiting factor in earthworm uptake. For all pharmaceuticals, this
was in the silt sand soil (soil 2.1), whilst the clayey loam soil (soil
2.4) generally had the lowest pore water concentrations (Fig. 1).
However, high internal concentrations at the end of the exposure
do not necessarily translate into highest BCFs. A BCF is a net result
of competing rates of uptake and elimination and therefore should
not be affected by the exposure medium concentration (Arnot and
Gobas, 2006). Additional studies are required to elucidate whether
earthworm uptake of pharmaceuticals is independent of exposure
medium concentration and to explore relationships between BCF
and pore water properties such as pH and dissolved organic matter.
Clearly many factors and processes in both the pore water andsoil are governing the fate and subsequent uptake of pharmaceu-
ticals into earthworms as current attempts to single out principal
factors are yet to be successful. However, considering uptake as a
combination of both soil and pore water parameters may offer a
better explanation. Results showed increased chemical uptake by
earthworms in soils which had decreasing soil organic matter
(SOM). This could be explained by the presence of SOM decreasing
the proportion of the chemical in pore water via sorption in-
teractions which in turn reduces potential for uptake. Our results
tend to agree that decreasing SOM leads to higher pore water
concentrations of the pharmaceuticals (Supplementary Figure 3).
For ﬂuoxetine we saw a marked decrease in pore water concen-
tration when there was an increase in organic carbon (OC) content
of the test soils. Relationships presented in Supplementary Figure 3
also show an increase in OC corresponds to a decrease in BCFs for
the various soils and thus ﬁts with previous research ﬁndings that
the SOM is regulating the bioavailable fraction of pharmaceuticals
in the pore water. This is also shown in the diclofenac exposure,
although to a lesser extent, with weak correlations especially be-
tween BCF and OC (Supplementary Figure 3).
For the neutral pharmaceuticals, orlistat and carbamazepine, an
increase in organic carbon content still followed a decrease in pore
water concentration. However, in contrast a decrease in pore water
concentration corresponded to an increase in BCF (Supplementary
Figure 3). Therewas aweak correlation between increasing BCF and
increasing OC content of the soils such that it could be inferred that
BCF is inversely related to pore water concentration for the neutral
chemicals and inversely related to OC content for the acid and basic
pharmaceuticals (Supplementary Figure 3). Clearly, complex
L.J. Carter et al. / Environmental Pollution 213 (2016) 922e931930interactions exist between SOM, pore water concentrations and
BCFs. Further experiments, using a wider variety of soil types,
would allow for appropriate exploration and conclusions to be
drawn. Speciﬁcally, for pharmaceuticals present in their unionised
form, where hydrophobic interactions dominate the sorption pro-
cess, future studies need to take into account how the “hard” car-
bon fraction of the soil inﬂuences the bioavailability of
pharmaceuticals. Hard carbon materials such as soot and black
carbon have been previously demonstrated to inﬂuence organic
chemical bioavailability in water-sediment systems (Cornelissen
and Gustafsson, 2005; Rust et al., 2004; Tang et al., 2007).
As one single soil type did not generate the largest BCFs for all
pharmaceuticals, our results demonstrate that earthworm uptake is
both a factor of soil type (including soil and pore water parameters)
as well as pharmaceutical physico-chemical properties. However, it
is clear that for some pharmaceuticals the inﬂuence of soil type on
the uptake and accumulation of pharmaceuticals is more signiﬁ-
cant (i.e. diclofenac) than for others (i.e. carbamazepine). Exposure
in the terrestrial system is a dynamic process and the availability of
chemicals to organisms is highly changeable. Whilst different soil
types may affect the uptake and accumulation of some chemicals,
BCF and BSAF results presented in this study suggest that the up-
take of pharmaceuticals are less inﬂuenced by soil chemistry.
Information on how soil properties can affect chemical uptake is
important in terms of both risk assessment and modelling.
Currently used, generalised models are unlikely to accurately
represent the potential uptake and risk associated with soil-borne
contaminants and, as our research shows, numerous factors are
involved in determining uptake. For modelling, a better under-
standing of biological factors inﬂuencing the uptake of chemicals
residing in soils is important to accurately estimate the bio-
accumulation potential. Additional work needs to explore the effect
of changing pH in the earthworm tissue and soil samples on the
uptake of ionisable chemicals and the subsequent implications of
this for exposure modelling scenarios. Speciﬁcally, changes in
earthworm tissue pHmay result inwider implications involving pH
dependent toxicity such as the ion trap phenomena previously
observed in algal cells (Neuwoehner and Escher, 2011), or negative
effects on earthworm internal environments. However, as it is not
clear which factors speciﬁcally lead to pH change, further studies
are needed to quantify and qualify these complicated processes.
This study represents the ﬁrst attempt to evaluate the complex
interplay between pharmaceutical chemical properties and soil
chemical properties and how these govern potential exposure
scenarios for a critical terrestrial organism. While there are many
confounding complexities and unanswered questions this work
represents a ﬁrst important step in understand the terrestrial fate
of pharmaceuticals, a critical component in understanding envi-
ronmental risk.
Detailed information on extraction procedures together with
extraction recoveries, a mass balance accounting for all radioac-
tivity in the experiment and information on the ionisation state of
the pharmaceuticals are provided in the Supplementary material.
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